LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,830 | -62.1% | 6,686,197 | -18.1% | 0.00% | -75.0% |
| Q2 2023 | $25,953 | +177.2% | 8,161,094 | +105.7% | 0.00% | +300.0% |
| Q1 2023 | $9,364 | -26.6% | 3,967,338 | +7.9% | 0.00% | -50.0% |
| Q4 2022 | $12,755 | -100.0% | 3,675,686 | -30.7% | 0.00% | -66.7% |
| Q3 2022 | $38,898,000 | +12.0% | 5,306,607 | -0.4% | 0.01% | +50.0% |
| Q2 2022 | $34,735,000 | +25.2% | 5,327,496 | -3.0% | 0.00% | +33.3% |
| Q1 2022 | $27,744,000 | -30.3% | 5,493,922 | +6.9% | 0.00% | -25.0% |
| Q4 2021 | $39,794,000 | -26.5% | 5,141,291 | +40.5% | 0.00% | -20.0% |
| Q3 2021 | $54,157,000 | +33.4% | 3,659,270 | +46.4% | 0.01% | +25.0% |
| Q2 2021 | $40,600,000 | – | 2,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |